492 top medical experts on Progressive Supranuclear Palsy across 34 countries and 30 U.S. states, including 386 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Progressive Supranuclear Palsy: A degenerative disease of the central nervous system characterized by balance difficulties; ocular motility disorders (supranuclear ophthalmoplegia); dysarthria; swallowing difficulties; and axial dystonia. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal mesencephalon; subthalamic nucleus; RED nucleus; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Basal Ganglia Diseases (3,177), Movement Disorders (2,573), Ophthalmoplegia (2,307), Tauopathies (1,975).
  4. Clinical Trials ClinicalTrials.gov : at least 116 including 4 Active, 55 Completed, 36 Recruiting
  5. Synonyms: Progressive Supranuclear Ophthalmoplegia,  Progressive Supranuclear Ophthalmoplegia,  Progressive Supranuclear Palsy 1,  Steele-Richardson-Olszewski Syndrome


  

        

                    


    Computing Expert Listing ...

);